Clover Health Investments (CLOV) Shares Outstanding (Weighted Average) (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $522.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 5.06% year-over-year to $522.2 million; the trailing twelve-month figure through Mar 2026 stood at $522.2 million (up 5.06% YoY), and the FY2025 full-year result was $512.0 million, up 4.48% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $522.2 million, up from $512.0 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $522.2 million in Q1 2026 and bottomed at $473.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $486.4 million (2024), against an average of $489.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) advanced 25.75%; it then climbed 0.65% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $476.2 million in 2022, then advanced by 1.25% to $482.2 million in 2023, then grew by 1.63% to $490.0 million in 2024, then climbed by 4.48% to $512.0 million in 2025, then rose by 2.0% to $522.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $522.2 million (Q1 2026), $512.0 million (Q4 2025), and $510.2 million (Q3 2025), per Business Quant data.

Peer Comparison